Aurion Res Ltd (AIRRF) 0.1688 $AIRRF Aurion and B2Gold

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aurion Res Ltd (AIRRF) 0.1688 $AIRRF

Aurion and B2Gold Channel Sample 9.8m at 6.5g/t Au at Kutuvuoma and Sample 21.2 g/t Au at a New Gold Target 1.6 km West of Kutuvuoma
Marketwired - Tue Feb 09, 11:10AM CST
Aurion Resources Ltd. ("Aurion" (TSX VENTURE: AU) and its partner B2Gold Corp. (TSX: BTO)(NYSE MKT: BTG)(NAMIBIAN: B2G); ("B2Gold" are pleased to report a series of encouraging gold results from its fall-2015 exploration program in northern Finland.
BTG: 2.18 (-0.08), BTO.TO: 2.77 (-0.10), AU.VN: 0.260 (+0.020)

Aurion Resources Signs Definitive Option Agreement with B2Gold on Gold Projects in Northern Finland
Marketwired - Wed Jan 20, 1:10PM CST
Aurion Resources Ltd. ("Aurion" (TSX VENTURE: AU) is pleased to report that, subsequent to a binding letter agreement, (see Press Release dated Aug 13, 2015), it has signed a formal definitive option agreement with B2Gold Corp. ("B2Gold" granting B2Gold the right to earn up to an undivided 75% interest in an approximately 25,000 ha project area, including the Kutuvuoma and Ahvenjarvi gold exploration projects, in Northern Finland.
AU.VN: 0.260 (+0.020)

Aurion Changes Auditors
Marketwired - Wed Jan 06, 1:53PM CST
Aurion Resources Ltd. (TSX VENTURE: AU) has changed its auditor from Deloitte LLP to Davidson and Company LLP.
AU.VN: 0.260 (+0.020)

TSX Venture Exchange Daily Bulletins
CNW Group - Mon Nov 16, 3:48PM CST
TSX VENTURE COMPANIES

Aurion Options Finnish Projects to B2Gold and Reports High Grade Results at Kutuvuoma and Ahvenjarvi
Marketwired - Thu Aug 13, 2:21PM CDT
Aurion Resources Ltd. ("Aurion" (TSX VENTURE: AU) is pleased to report that it has signed a binding letter agreement with B2Gold Corp. (TSX: BTO)(NYSE MKT: BTG)(NAMIBIAN: B2G); ("B2Gold" granting B2Gold the right to earn up to an undivided 75% interest of an approximately 25,000 ha project area that includes the Kutuvuoma and Ahvenjarvi projects.
BTG: 2.18 (-0.08), BTO.TO: 2.77 (-0.10), AU.VN: 0.260 (+0.020)

Aurion Amends Logan Pass Agreement
Marketwired - Fri Jun 19, 3:16PM CDT
Aurion Resources Ltd. ("Aurion" (TSX VENTURE: AU) reports that Genesis Gold Corp. ("Genesis" has agreed to amend the underlying Logan Pass lease with an option to purchase agreement for a second time. Aurion has a 15 year lease with an option to purchase a 100% interest in 8 unpatented claims, subject to a 2% NSR. Pursuant to the original agreement, executed in 2010, the consideration payable by Aurion for the lease to purchase option are by making annual cash payments starting at US$25,000 increasing to a maximum US$125,000. The option to purchase can be executed at any time by making a one-time US$3 million cash payment less any payments already made.
AU.VN: 0.260 (+0.020)

Aurion Amends Purchase Agreement With Dragon
Marketwired - Tue Mar 10, 2:16PM CDT
Aurion Resources Ltd. ("Aurion" (TSX VENTURE: AU) is pleased to announce that it has executed an agreement ("Letter Agreement" with Dragon Mining Limited ("Dragon" to amend the Definitive Purchase Agreement ("Agreement" for the acquisition of the Kutuvuoma and Silasselka Projects ("Projects" in northern Finland.
AU.VN: 0.260 (+0.020)

Aurion Discovers New Gold Mineralization in Northern Finland
Marketwired - Thu Jan 15, 7:03AM CST
Aurion Resources Ltd. ("Aurion" (TSX VENTURE: AU) is pleased to provide the following update on its inaugural Northern Finland exploration program conducted this past fall which included reconnaissance prospecting, geological mapping and trenching.
AU.VN: 0.260 (+0.020)

Aurion Receives Key Permits at Logan Pass
Marketwired - Mon Oct 27, 7:32AM CDT
Aurion Resources Ltd. ("Aurion" (TSX VENTURE: AU) is pleased to report that it has received The U.S. Bureau of Land Management's ("BLM" Record of Decision confirming approval for a Plan of Operations for its Logan Pass carlin-type gold project in Nevada. The approved Plan of Operations allows Aurion up to 50 acres for exploration and development drilling in two primary target areas within its core group of claims.
AU.VN: 0.260 (+0.020)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading